Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT05587738
Registration number
NCT05587738
Ethics application status
Date submitted
17/10/2022
Date registered
20/10/2022
Date last updated
15/03/2023
Titles & IDs
Public title
Human Papillomavirus in Young People Epidemiological Research 4
Query!
Scientific title
A Cross-sectional Study to Evaluate the Prevalence of HPV in Gay and Bisexual Men Aged 21-25 Years in Australia
Query!
Secondary ID [1]
0
0
15/22
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
HYPER4
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Human Papillomavirus Infection
0
0
Query!
HPV
0
0
Query!
HPV Infection
0
0
Query!
Anal Cancer
0
0
Query!
Cancer
0
0
Query!
Men
0
0
Query!
HPV 16 Infection
0
0
Query!
Condition category
Condition code
Infection
0
0
0
0
Query!
Studies of infection and infectious agents
Query!
Infection
0
0
0
0
Query!
Other infectious diseases
Query!
Infection
0
0
0
0
Query!
Sexually transmitted infections
Query!
Cancer
0
0
0
0
Query!
Bowel - Anal
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Prevalence of quadrivalent vaccine HPV types
Query!
Assessment method [1]
0
0
The oral, penile and anal prevalence of quadrivalent vaccine types (6, 11, 16 and 18)
Query!
Timepoint [1]
0
0
Baseline
Query!
Primary outcome [2]
0
0
Prevalence of type-specific HPV types
Query!
Assessment method [2]
0
0
The oral, penile and anal prevalence of type-specific HPV types
Query!
Timepoint [2]
0
0
Baseline
Query!
Eligibility
Key inclusion criteria
* Men aged 21 to 25 years old in 2023-2024
* Same-sex attracted
* Residing in Australia since 2013
Query!
Minimum age
21
Years
Query!
Query!
Maximum age
25
Years
Query!
Query!
Sex
Males
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Unable to complete all study requirements in English
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2023
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
31/12/2024
Query!
Actual
Query!
Sample size
Target
500
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
0
0
Melbourne Sexual Health Centre - Melbourne
Query!
Recruitment postcode(s) [1]
0
0
3053 - Melbourne
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Monash University
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
The Alfred
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Other collaborator category [2]
0
0
Other
Query!
Name [2]
0
0
University of Melbourne
Query!
Address [2]
0
0
Query!
Country [2]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
Anal cancer is overrepresented among gay, bisexual and other men who have sex with men (MSM), particularly those living with HIV. Australia was the first country to introduce a publicly funded national HPV vaccination program in 2007. This program was expanded to include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to 15 years. The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV among 500 young gay and bisexual men aged 21-25 years who were eligible for the school-based gender-neutral quadrivalent vaccination program. Participants will be required to complete a questionnaire and provide samples for HPV testing. No follow-up visits will be required.
Query!
Trial website
https://clinicaltrials.gov/study/NCT05587738
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Eric Chow, PhD
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
+61393416233
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT05587738
Download to PDF